Docetaxel in Treating Patients With Stage IV Prostate Cancer

Completed · Phase 2

Conditions studied: Pain, Prostate Cancer

In brief

RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. PURPOSE: Phase II trial of docetaxel in treating patients who have stage IV prostate cancer that has not responded to hormone therapy.

Key facts

Study ID

NCT00003781

Run by

OHSU Knight Cancer Institute

People needed

25

Starts

1998-12-01

Expected to finish

2003-06-01

Last updated by the study team

2017-04-28

Who can join

Age: 18 and older, up to 120. Sex: male. Healthy volunteers: not accepted.

Where it is running

• OHSU Knight Cancer Institute — Portland, Oregon, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.